--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY ...

The Company has been selected to provide an oral presentation featuring clinical data from its ongoing Phase 1 clinical trial of FT819, its off-the-shelf, CD19-targeted, 1XX CAR T-cell product ...

This Phase I dose-escalation study in patients with advanced solid tumors was performed to determine the MTD, overall safety, pharmacokinetic (PK) profile and anti-tumor activity of afatinib ...

Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK Correspondence to Sarah Hanson, Norwich Medical School, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK; s.hanson{at}uea ...

For several years now the term “retail media” has been buzzing around both retail and media circles. Whether you’re looking for a deeper understanding of the implications and applications of retail ...

Evan and Michelle welcome Adam Schefter, ESPN Senior NFL Insider to the show for his weekly spot. What made Rodgers finally decide to sign with the Steelers? Just how serious is Anthony Richardson ...

Ideally, companies should begin engaging KOLs around 24 months before the planned launch, during phase 2 of the drug’s development. There are many ways to engage thought leaders via medical ...